ClinConnect ClinConnect Logo
Search / Trial NCT04865276

Adaptation and Evaluation of a Culturally and Gender Relevant Tobacco Cessation Among Women in Brazil: an Integrated MHealth Approach

Launched by UNIVERSITY OF ALABAMA AT BIRMINGHAM · Apr 25, 2021

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying a new program designed to help women in Brazil quit smoking. It combines support from trained community health workers with a mobile app that provides additional resources and encouragement for quitting tobacco. The goal is to make this program culturally relevant and tailored specifically for women, particularly those from low-income backgrounds. Researchers will first test the program to see how well it works and if it's easy to use, then they will compare it to an existing program that includes home visits from community health workers.

To participate, women must be at least 18 years old, currently smoke tobacco, and be willing to try to quit. There are no specific health issues that would exclude someone from joining. If you take part, you can expect support from both a community health worker and through the mobile app, which will help track your progress and provide motivation. If this new approach proves effective, it could serve as a model for similar programs in other communities, including those in the U.S.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • 18 years of age
  • Current tobacco use
  • Willingness to quit tobacco use
  • resident in the town assigned to intervention or control
  • Exclusion Criteria:
  • None

About University Of Alabama At Birmingham

The University of Alabama at Birmingham (UAB) is a prominent academic institution and research hub dedicated to advancing healthcare through innovative clinical trials. Renowned for its commitment to medical discovery and education, UAB conducts cutting-edge research across a wide array of disciplines, including oncology, cardiology, neurology, and public health. With a robust infrastructure for clinical research, UAB fosters collaboration among interdisciplinary teams, leveraging state-of-the-art facilities and resources to enhance the translation of scientific findings into effective treatments and interventions. As a leader in clinical research, UAB aims to improve patient outcomes and contribute to the broader medical community through rigorous trial design and implementation.

Locations

Londrina, Paraná, Brazil

Londrina, , Brazil

Patients applied

0 patients applied

Trial Officials

Isabel C Scarinci, PhD

Principal Investigator

University of Alabama at Birmingham

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials